{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:50:55Z","timestamp":1790175055795,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ijpharm.2016.03.026","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T20:27:25Z","timestamp":1458246445000},"page":"262-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Microencapsulation of rifampicin for the prevention of endophthalmitis: In vitro release studies and antibacterial assessment"],"prefix":"10.1016","volume":"505","author":[{"given":"Mi Yeon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyad","family":"Almouazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Fessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Kodjikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.03.026_bib0005","series-title":"Biophysical Science","first-page":"205","article-title":"Light and the eye","author":"Ackerman","year":"1962"},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0928-0987(98)00005-0","article-title":"Evaluation of biodegradable rifampicin-bearing microsphere formulations using a stability-indicating high-performance liquid chromatographic assay","volume":"7","author":"Bain","year":"1998","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0015","first-page":"1","article-title":"Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)\/poly(lactic acid) microspheres for over 3 months","author":"Bertram","year":"2008","journal-title":"J. Microencapsulation"},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/AAC.00691-09","article-title":"Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles","volume":"54","author":"Brown","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1023\/A:1015841715384","article-title":"Controlled delivery system for proteins based on poly(lactic\/glycolic acid) microspheres","volume":"8","author":"Cohen","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0008-4182(00)80124-6","article-title":"Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery","volume":"35","author":"Colleaux","year":"2000","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0886-3350(89)80092-6","article-title":"Bacterial adhesion to intraocular lenses","volume":"15","author":"Dilly","year":"1989","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijpharm.2011.05.007","article-title":"Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery","volume":"414","author":"Doan","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/AAC.45.1.363-366.2001","article-title":"Therapeutic efficacy of poly(d,l-lactide-Co-Glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice","volume":"45","author":"Dutt","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0050","series-title":"Antibiotic and Chemotherapy: Anti-infective Agents and Their Use in Therapy","author":"Finch","year":"2003"},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2013.04.012","article-title":"Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections","volume":"170","author":"Gilchrist","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2006.06.005","article-title":"Preparation of vancomycin microparticles: importance of preparation parameters","volume":"324","author":"Hachicha","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0065","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jcrs.2007.01.008","article-title":"In vitro efficacy of newly designed vancomycin-based microparticles","volume":"33","author":"Hachicha","year":"2007","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.colsurfb.2009.08.003","article-title":"The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method","volume":"74","author":"Hamishehkar","year":"2009","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.colsurfb.2004.08.016","article-title":"Preparation and properties of monodispersed rifampicinloaded poly(lactide-co-glycolide)","volume":"39","author":"Ito","year":"2004","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/02652040802141039","article-title":"Poly(epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W\/O\/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics","volume":"26","author":"Karatas","year":"2009","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0161-6420(02)01760-8","article-title":"Infectious keratitis after LASIK","volume":"110","author":"Karp","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/aos.12684","article-title":"Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta-analysis","volume":"93","author":"Kessel","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0095","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1167\/iovs.03-0185","article-title":"Biofilm formation on intraocular lenses by a clinical strain encoding the ica locus: a scanning electron microscopy study","volume":"44","author":"Kodjikian","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0100","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1167\/iovs.09-4694","article-title":"Experimental intracameral injection of vancomycin microparticles in rabbits","volume":"51","author":"Kodjikian","year":"2010","journal-title":"Invest. Ophtalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/10445490260099692","article-title":"Immunology of Staphylococcal biofilm infections in the eye: new tools to study biofilm endophthalmitis","volume":"21","author":"Leid","year":"2002","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0110","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2147\/OPTH.S59776","article-title":"Intracameral cefuroxime and moxifloxacin used as endophthalmitis prophylaxis after cataract surgery: systematic review of effectiveness and cost-effectiveness","volume":"8","author":"Linertova","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2004.11.027","article-title":"PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution","volume":"290","author":"Mainardes","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.colsurfb.2004.03.018","article-title":"Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin","volume":"36","author":"Makino","year":"2004","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2007.06.008","article-title":"Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method","volume":"68","author":"Mao","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2003.12.006","article-title":"Optimisation of aciclovir poly-lactide-co-glycolide microspheres for intravitreal administration using a factorial design study","volume":"273","author":"Mart\u00ednez-Sancho","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0135","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0886-3350(97)80081-8","article-title":"Anterior chamber contamination during cataract surgery with intraocular lens implantation","volume":"23","author":"Mistlberger","year":"1997","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0140","first-page":"3125","article-title":"Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy","volume":"33","author":"Moritera","year":"1992","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0886-3350(02)01483-9","article-title":"Bacterial endophthalmitis alter small-incision cataract surgery: effect of incision placement and intraocular lens type","volume":"29","author":"Nagaki","year":"2003","journal-title":"J. Cataract Refract. Surg."},{"issue":"Suppl. 2","key":"10.1016\/j.ijpharm.2016.03.026_bib0150","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.survophthal.2004.01.002","article-title":"Reducing the risk of postoperative endophthalmitis","volume":"49","author":"Olson","year":"2004","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5173(99)00216-1","article-title":"Pseudolatex preparation using a novel emulsion-diffusion process involving direct displacement of partially water-miscible solvents by distillation","volume":"188","author":"Quintanar-Guerrero","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0160","unstructured":"Quintanar-Guerrero D., Fessi H., Doelker E., Allemann E., 2000, Method for preparing vesicular nanocapsules, Patent EP 1003488, published 31.05.2000."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0165","first-page":"960","article-title":"Infectious endophtalmitis","volume":"42","author":"Salvanet-Bouccara","year":"1992","journal-title":"Rev. Prat."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0170","series-title":"Physiologie Oculaire","first-page":"122","article-title":"Physiologie de l'Humeur Aqueuse et de la Pression Oculaire","author":"Saraux","year":"1983"},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0175","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0886-3350(03)00617-5","article-title":"Effect of prophylactic antibiotics on antimcrobial resistance of viridans streptococci in the normal flora of cataract surgery patients","volume":"30","author":"Sepp\u00e4l\u00e4","year":"2004","journal-title":"J. Cataract Refract. Surg."},{"issue":"Pt. 3","key":"10.1016\/j.ijpharm.2016.03.026_bib0180","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/eye.1989.44","article-title":"Bacterial contamination of intraocular and extraocular fluids during extracapsular cataract extraction","volume":"3","author":"Sherwood","year":"1989","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0185","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/bjo.68.8.520","article-title":"Bacterial contamination of intraocular lens surgery","volume":"68","author":"Vafidis","year":"1984","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0190","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1093\/cid\/cir184","article-title":"Why do we use 600mg of rifampicin in tuberculosis treatment?","volume":"52","author":"Van Ingen","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0195","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1055\/s-2008-1034989","article-title":"[Clearance of liposome-incorporated ciprofloxacin after intravitreal injection in rabbit eyes]","volume":"213","author":"Wiechens","year":"1998","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"10.1016\/j.ijpharm.2016.03.026_bib0200","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/02652040010018100","article-title":"Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles","volume":"18","author":"Yeh","year":"2001","journal-title":"J. Microencapsul."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316302265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316302265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T07:58:55Z","timestamp":1536911935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316302265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0378517316302265"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.026","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microencapsulation of rifampicin for the prevention of endophthalmitis: In vitro release studies and antibacterial assessment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}